Evidence map›Paper›PMID 42399471›Full record

ArticleProtoplasma2026

Tracing the origin of the tobacco BY-2 cell line.

Pavel Jelínek, Jan Petrášek

Abstract read
PubMed Publisher
In one paragraph

Article in Protoplasma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pavel JelínekDepartment of Experimental Plant Biology, Faculty of Science, Charles University, Viničná 5, 128 00, Prague 2, Czech Republic.ORCID http://orcid.org/0000-0001-9236-2866
Jan PetrášekDepartment of Experimental Plant Biology, Faculty of Science, Charles University, Viničná 5, 128 00, Prague 2, Czech Republic. petrasek@natur.cuni.cz.ORCID http://orcid.org/0000-0002-6719-2735

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most frequently used plant cell lines is the tobacco cell line BY-2, which was established from Nicotiana tabacum L. cv. Bright Yellow 2 plants. However, surprisingly, after more than 50 years, the original information about the authors, the place and the method of its establishment is quite laborious to obtain. This could be important for any de novo derivation of highly proliferative cell lines. In this brief reflection article, we summarise the publicly available information on the origin of BY-2 in the 1960s, when it was used in applied research at the Central Research Institute of Japan Tobacco & Salt Public Corporation (JTS). Thanks largely to Professor Toshiyuki Nagata's activities, it spread to the rest of the world in the 1980s, becoming a cellular model for basic research into the cell cycle, membrane and cytoskeletal dynamics, and many other processes. Available literature suggests that the BY-2 cell line was derived from calli induced on the stems of seedlings of the Bright Yellow-2 Virginia-type tobacco cultivar. We hope that the information we have gathered will be useful for everyone working with, or planning to use, the BY-2 cell line. We also hope that it will encourage efforts to search for more details in old Japanese patent records that could be used to establish new, highly proliferating lines.

Indexed as

Bright YellowBY-2Cell linesNicotiana tabacumTobacco

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.